Downregulation of L1CAM inhibits proliferation, invasion and arrests cell cycle progression in pancreatic cancer cells in vitro

Experimental and Therapeutic Medicine

Volumn 7, Issue 4, 2014, Pages 785-790

  Ben, Qiwen ^a   An, Wei ^b   Fei, Jian ^a   Xu, Maojin ^b   Li, Guixiang ^b   Li, Zhaoshen ^b   Yuan, Yaozong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Invasion; L1cam; Pancreatic cancer; Proliferation

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE CELL ADHESION MOLECULE L1; SHORT HAIRPIN RNA; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL COUNTING; CELL CYCLE ARREST; CELL CYCLE PHASE; CELL CYCLE PROGRESSION; CELL INVASION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PANCREAS CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; WESTERN BLOTTING;

EID: 84896726712     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1519     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
2. Neoptolemos JP, Stocken DD, Friess H, et al; European Study Group for Pancreatic Cancer: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350: 1200-1210, 2004.
3. Guo X and Cui Z: Current diagnosis and treatment of pancreatic cancer in China. Pancreas 31: 13-22, 2005.
4. Schneider G, Siveke JT, Eckel F and Schmid RM: Pancreatic cancer: basic and clinical aspects. Gastroenterology 128: 1606-1625, 2005.
5. Fransen E, Lemmon V, Van Camp G, Vits L, Coucke P and Willems PJ: CRASH syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1. Eur J Hum Genet 3: 273-284, 1995.
6. Kajiwara Y, Ueno H, Hashiguchi Y, et al: Expression of l1 cell adhesion molecule and morphologic features at the invasive front of colorectal cancer. Am J Clin Pathol 136: 138-144, 2011.
7. Schäfer H, Dieckmann C, Korniienko O, et al: Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma. Cancer Lett 319: 66-82, 2012.
8. Bao S, Wu Q, Li Z, et al: Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 68: 604-6048, 2008.
9. Hai J, Zhu CQ, Bandarchi B, et al: L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Clin Cancer Res 18: 1914-1924, 2012.
10. Li S, Jo YS, Lee JH, et al: L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma. Clin Cancer Res 15: 7345-7351, 2009.
11. Ben QW, Wang JC, Liu J, et al: Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma. Ann Surg Oncol 17: 2213-2221, 2010.
12. Issa Y, Nummer D, Seibel T, et al: Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration. J Mol Med (Berl) 87: 99-112, 2009.
13. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M and Montgomery AM: Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem 279: 28880-28888, 2004.
14. Elbashir SM, Harborth J, Weber K and Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213, 2002.
15. Zecchini S, Bianchi M, Colombo N, et al: The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res 68: 1110-1118, 2008.
16. Gast D, Riedle S, Riedle S, et al: L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int J Cancer 115: 658-665, 2005.
17. Gavert N, Conacci-Sorrell M, Gast D, et al: L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 168: 633-642, 2005.
18. Arlt MJ, Novak-Hofer I, Gast D, et al: Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res 66: 936-943, 2006.
19. Kiefel H, Bondong S, Erbe-Hoffmann N, et al: L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression. Oncogene 29: 4766-4778, 2010.
20. Bondong S, Kiefel H, Hielscher T, et al: Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation. Ann Oncol 23: 1795-1802, 2012.
21. Izumoto S and Yoshimine T: Role of neural cell adhesion molecule L1 in glioma invasion. Nihon Rinsho 63 (Suppl 9): 74-78, 2005 (In Japanese).
22. Voura EB, Ramjeesingh RA, Montgomery AM and Siu CH: Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol Biol Cell 12: 2699-2710, 2001.
23. Min JK, Kim JM, Li S, et al: L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma. Clin Cancer Res 16: 3571-3580, 2010.
24. Gavert N, Ben-Shmuel A, Lemmon V, Brabletz T and Ben-Zeev A Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci 123: 2135-2143, 2010.
25. Mechtersheimer S, Gutwein P, Agmon-Levin N, et al: Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol 155: 661-673, 2001.
26. Gavert N, Sheffer M, Raveh S, et al: Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res 67: 7703-7712, 2007.
27. Sebens Müerköster S, Werbing V, Sipos B, et al: Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene 26: 2759-2768, 2007.
28. Boo YJ, Park JM, Kim J, et al: L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Ann Surg Oncol 14: 1703-1711, 2007.
29. Kodera Y, Nakanishi H, Ito S, et al: Expression of L1 cell adhesion molecule is a significant prognostic factor in pT3-stage gastric cancer. Anticancer Res 29: 4033-4039, 2009.
30. Rawnaq T, Kleinhans H, Uto M, et al: Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma. Anticancer Res 29: 1195-1199, 2009.
31. Schröder C, Schumacher U, Fogel M, et al: Expression and prognostic value of L1-CAM in breast cancer. Oncol Rep 22: 1109-1117, 2009.
32. Schaefer AW, Kamiguchi H, Wong EV, Beach CM, Landreth G and Lemmon V: Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization. J Biol Chem 274: 37965-37973, 1999.
33. Gast D, Riedle S, Issa Y, et al: The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene 27: 1281-1289, 2008.
34. Cheng L, Lemmon S and Lemmon V: RanBPM is an L1-interacting protein that regulates L1-mediated mitogen-activated protein kinase activation. J Neurochem 94: 1102-1110, 2005.
35. Kiefel H, Bondong S, Pfeifer M, et al: EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation. Carcinogenesis 33: 1919-1929, 2012.
36. Shtutman M, Levina E, Ohouo P, Baig M and Roninson IB: Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res 66: 11370-11380, 2006.
37. Huszar M, Pfeifer M, Schirmer U, et al: Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas. J Pathol 220: 551-561, 2010.
38. Tischler V, Pfeifer M, Hausladen S, et al: L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Mol Cancer 10: 127, 2011.
39. Geismann C, Morscheck M, Koch D, et al: Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1-and slug-dependent: role in malignant transformation of pancreatic cancer. Cancer Res 69: 4517-4526, 2009.
40. Gavert N, Vivanti A, Hazin J, Brabletz T and Ben-Zeev A: L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol Cancer Res 9: 14-24, 2011.